EUVIMEDOpdag EUVIMED
BeobachtungsstudieOpen access · CC BY-NC-ND 4.0

COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study

Álvaro Tamayo-Velasco, Rocío López-Herrero, Lara María Gómez-García, Laura Sánchez-de Prada, Gerardo Aguilar-Monserrate, Marta Martín-Fernández, Miguel Bardají-Carrillo, Alejandro Álvaro-Meca, Eduardo Tamayo, Salvador Resino, José Pablo Miramontes-González, María Jesús Peñarrubia-Ponce

Journal of Infection and Public Health · 2024

DOI: 10.1016/j.jiph.2024.04.005 ↗

At a glance

Beobachtungsstudie in Journal of Infection and Public Health, 2024. Written by Álvaro Tamayo-Velasco and 11 co-authors. Institution: Hematology and Hemotherapy Department, Hospital Clínico Universitario de Valladolid, 47003 Valladolid, Spain; Centro de Investigación Biomédica en Re…. Major MEDLINE topics: COVID-19, Antifungal Agents, Hematologic Neoplasms, Invasive Pulmonary Aspergillosis. Cited 8 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Instituto de Salud Carlos III.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

BACKGROUND: COVID-19-associated pulmonary aspergillosis (CAPA) has emerged as a relatively common complication. Multiple studies described this relationship in critical patients, however its incidence and outcome in other risk groups such as immunosuppressed patients remains unknown. In this sense, we aimed to evaluate the rates and outcomes of CAPA in hematological patients and according to the different hematological malignances, comparing to invasive pulmonary aspergillosis (IPA) in non-COVID-19 ones. METHODS: Nationwide, population-based and retrospective observational cohort study including all adult patients with hematological malignancies admitted in Spain since March 1, 2020 to December 31, 2021. The main outcome variable was the diagnosis of IPA during hospitalization in hematological patients with or without COVID-19 at admission. The rate of CAPA compared to IPA in non-COVID-19 patients in each hematological malignancy was also performed, as well as survival curve analysis. FINDINGS: COVID-19 was diagnosed in 3.85 % (4367 out of 113,525) of the hematological adult inpatients. COVID-19 group developed more fungal infections (5.1 % vs. 3 %; p < 0.001). Candida spp. showed higher rate in non-COVID-19 (74.2 % vs. 66.8 %; p = 0.015), meanwhile Aspergillus spp. confirmed its predominance in COVID-19 hematological patients (35.4 % vs. 19.1 %; p < 0.001). IPA was diagnosed in 703 patients and 11.2 % (79 cases) were CAPA. The multivariate logistic regression analysis found that the diagnosis of COVID-19 disease at hospital admission increased more than two-fold IPA development [OR: 2.5, 95CI (1.9-3.1), p < 0.001]. B-cell malignancies - specifically B-cell non-Hodgkin lymphoma, multiple myeloma, chronic lymphocytic leukemia and acute lymphoblastic leukemia - showed between four- and six-fold higher CAPA development and 90-day mortality rates ranging between 50 % and 72 %. However, myeloid malignancies did not show higher CAPA rates compared to IPA in non-COVID-19 patients. CONCLUSION: COVID-19 constitutes an independent risk factor for developing aspergillosis in B-cell hematological malignancies and the use of antifungal prophylaxis during hospitalizations may be warranted.

Subjects

MeSH terms (MEDLINE)

COVID-19Antifungal AgentsHematologic NeoplasmsInvasive Pulmonary AspergillosisHumansMaleFemaleRetrospective StudiesMiddle AgedAgedSpainAdultSARS-CoV-2Pulmonary AspergillosisRisk FactorsIncidenceImmunocompromised HostHospitalization

Author keywords

Antifungal prophylaxisCOVID-19-associated pulmonary aspergillosis (CAPA)Fungal infectionsImmunosuppressed infections, hematological patientsSARS-CoV-2

Substances

Antifungal Agents

Authors and institutions

  • Hematology and Hemotherapy Department, Hospital Clínico Universitario de Valladolid, 47003 Valladolid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos…
  • BioCritic. Group for Biomedical Research in Critical Care Medicine, 47005 Valladolid, Spain; Anesthesiology and Critical Care Department, Hospital Clínico Universitario de Valladolid, 47003 Valladolid, Spain; Department…
  • Hematology and Hemotherapy Department, Hospital Clínico Universitario de Valladolid, 47003 Valladolid, Spain.
  • BioCritic. Group for Biomedical Research in Critical Care Medicine, 47005 Valladolid, Spain; Microbiology Department, Hospital Universitario Rio Hortega, 47012 Valladolid, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain; BioCritic. Group for Biomedical Research in Critical Care Medicine, 47005 Valladolid…
  • BioCritic. Group for Biomedical Research in Critical Care Medicine, 47005 Valladolid, Spain; Anesthesiology and Critical Care Department, Hospital Clínico Universitario de Valladolid, 47003 Valladolid, Spain.

Funding

  • Instituto de Salud Carlos III

Cite

APA

Tamayo-Velasco, Á., López-Herrero, R., Gómez-García, L. M., Sánchez-de Prada, L., Aguilar-Monserrate, G., Martín-Fernández, M., Bardají-Carrillo, M., Álvaro-Meca, A., Tamayo, E., Resino, S., Miramontes-González, J. P., & Peñarrubia-Ponce, M. J. (2024). COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2024.04.005

Vancouver

Tamayo-Velasco Á, López-Herrero R, Gómez-García LM, Sánchez-de Prada L, Aguilar-Monserrate G, Martín-Fernández M, et al. COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study. Journal of Infection and Public Health. 2024. doi:10.1016/j.jiph.2024.04.005

BibTeX
@article{TamayoVelasco2024,
  author = {Tamayo-Velasco, Álvaro and López-Herrero, Rocío and Gómez-García, Lara María and Sánchez-de Prada, Laura and Aguilar-Monserrate, Gerardo and Martín-Fernández, Marta and Bardají-Carrillo, Miguel and Álvaro-Meca, Alejandro and Tamayo, Eduardo and Resino, Salvador and Miramontes-González, José Pablo and Peñarrubia-Ponce, María Jesús},
  title = {COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study},
  journal = {Journal of Infection and Public Health},
  year = {2024},
  doi = {10.1016/j.jiph.2024.04.005}
}
Start for free →